The 21st Century has seen the boom in development and introduction of electronic medical records. These systems have been developed focusing on administration of patient care on healthcare facility level and, later, on state healthcare system level.
It turned out to be that the data collection and storage process was and still is not easily compatible with clinical research and practice. It is the DNA of most companies working with healthcare data to make this data available for wider research.
Streamlining of medical data: data classification and clustering to enhance EHR and EMR systems and implement best practices to increase ROI and introduce tangible metrics in organization performance
Insights in clinical dossiers via clinical decision-making support systems, that are based on real world data analysis and allow for more effective
Personalized medicine: RWD can be used to identify genetic and molecular markers that predict response to drugs, which can be used to personalize treatment options
Access to Traverse Health Partner network – best in class 2nd opinion services and advanced analytics for medical data. As well as increased exposure to biomedical research via clinical trials
Empowering Health data
See also
Pharmaceutical, biotech and medical device companies